TY - JOUR
T1 - Evidence-based guideline update
T2 - Intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials - Report of the therapeutics and technology assessment subcommittee of the american academy of neurology and the american clinical neurophysiology society
AU - Nuwer, M. R.
AU - Emerson, R. G.
AU - Galloway, G.
AU - Legatt, A. D.
AU - Lopez, J.
AU - Minahan, R.
AU - Yamada, T.
AU - Goodin, D. S.
AU - Armon, C.
AU - Chaudhry, V.
AU - Gronseth, G. S.
AU - Harden, C. L.
N1 - Funding Information:
Study funding:This evidence-based guideline was funded by the American Academy of Neurology and the American Clinical Neurophysiology Society. No author received honoraria or financial support to develop this document.
PY - 2012/2/21
Y1 - 2012/2/21
N2 - Objective: To evaluate whether spinal cord intraoperative monitoring (IOM) with somatosensory and transcranial electrical motor evoked potentials (EPs) predicts adverse surgical outcomes. Methods: A panel of experts reviewed the results of a comprehensive literature search and identified published studies relevant to the clinical question. These studies were classified according to the evidence-based methodology of the American Academy of Neurology. Objective outcomes of postoperative onset of paraparesis, paraplegia, and quadriplegia were used because no randomized or masked studies were available. Results and Recommendations: Four Class I and 8 Class II studies met inclusion criteria for analysis. The 4 Class I studies and 7 of the 8 Class II studies reached significance in showing that paraparesis, paraplegia, and quadriplegia occurred in the IOM patients with EP changes compared with the IOM group without EP changes. All studies were consistent in showing all occurrences of paraparesis, paraplegia, and quadriplegia in the IOM patients with EP changes, with no occurrences of paraparesis, paraplegia, and quadriplegia in patients without EP changes. In the Class I studies, 16%-40% of the IOM patients with EP changes developed postoperative-onset paraparesis, paraplegia, or quadriplegia. IOM is established as effective to predict an increased risk of the adverse outcomes of paraparesis, paraplegia, and quadriplegia in spinal surgery (4 Class I and 7 Class II studies). Surgeons and other members of the operating team should be alerted to the increased risk of severe adverse neurologic outcomes in patients with important IOM changes (Level A).
AB - Objective: To evaluate whether spinal cord intraoperative monitoring (IOM) with somatosensory and transcranial electrical motor evoked potentials (EPs) predicts adverse surgical outcomes. Methods: A panel of experts reviewed the results of a comprehensive literature search and identified published studies relevant to the clinical question. These studies were classified according to the evidence-based methodology of the American Academy of Neurology. Objective outcomes of postoperative onset of paraparesis, paraplegia, and quadriplegia were used because no randomized or masked studies were available. Results and Recommendations: Four Class I and 8 Class II studies met inclusion criteria for analysis. The 4 Class I studies and 7 of the 8 Class II studies reached significance in showing that paraparesis, paraplegia, and quadriplegia occurred in the IOM patients with EP changes compared with the IOM group without EP changes. All studies were consistent in showing all occurrences of paraparesis, paraplegia, and quadriplegia in the IOM patients with EP changes, with no occurrences of paraparesis, paraplegia, and quadriplegia in patients without EP changes. In the Class I studies, 16%-40% of the IOM patients with EP changes developed postoperative-onset paraparesis, paraplegia, or quadriplegia. IOM is established as effective to predict an increased risk of the adverse outcomes of paraparesis, paraplegia, and quadriplegia in spinal surgery (4 Class I and 7 Class II studies). Surgeons and other members of the operating team should be alerted to the increased risk of severe adverse neurologic outcomes in patients with important IOM changes (Level A).
UR - http://www.scopus.com/inward/record.url?scp=84858145427&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858145427&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e318247fa0e
DO - 10.1212/WNL.0b013e318247fa0e
M3 - Article
C2 - 22351796
AN - SCOPUS:84858145427
SN - 0028-3878
VL - 78
SP - 585
EP - 589
JO - Neurology
JF - Neurology
IS - 8
ER -